Hong Kong biotech company Prenetics is going public through a merger with Artisan Acquisition — a SPAC backed by Adrian Cheng, CEO of New World Development.
Hong Kong start-up Prenetics to list in the U.S. through $1.7 billion SPAC deal
Share This Story, Choose Your Platform!
About the Author: David Hilbern
